Research
Genetic and phenotypic plasticity of cancer : C. Sardet

activities

The INSERM team “Genetic and Phenotypic Plasticity of Cancer” was co-created in 2015 by C Sardet and C. Theillet. The team has close links with clinical oncology (Pr W Jacot) and oncological surgery (Pr PE Colombo) at the Montpellier Cancer Institute (ICM / Centre de Lutte Contre le Cancer). Our projects are focused on Triple-Negative Breast Cancer (TNBC) and High-Grade Ovarian Cancer (HGOC). They intend to identify and target the “Achille’s heels” and various adaptative strategies (DNA repair, metabolism, signaling) of these tumors and of their treatment-resistant cell populations responsible for recurrence. 

More

MAIN PUBLICATIONS

Tabet I, Candiello E, Fenou L, Velazquez C, Jacot W, Ribeyre C, Sardet C, Theillet C Replication poison treated BRCA1-deficient breast cancers are prone to MRE11 over-resection resulting in single strand DNA accumulation and mitotic catastrophe.. Cancer Research. 2025;in press.

Orhan E, Velazquez C, Tabet I, Fenou L, Rodier G, Orsetti B, Jacot W, Sardet C, Theillet C CDK inhibition results in pharmacologic BRCAness increasing sensitivity to olaparib in BRCA1-WT and olaparib resistant in Triple Negative Breast Cancer. Cancer Lett. 2024;589. doi:10.1016/j.canlet.2024.216820

du Manoir S, Delpech H, Orsetti B, Jacot W, Pirot N, Noel J, Colombo P-E, Sardet C, Theillet C In high-grade ovarian carcinoma, platinum-sensitive tumor recurrence and acquired-resistance derive from quiescent residual cancer cells that overexpress CRYAB, CEACAM6, and SOX2. J Pathol. 2022;257(3):367-378. doi:10.1002/path.5896

Lacroix M, Rodier G, Kirsh O, Delpech H, Seyran B, Gayte L, Casas F, Pessemesse L, Heuillet M, Bellvert F, Portais J-C, Berthet C, Bernex F, Brivet M, Boutron A, Le Cam L, Sardet C E4F1 controls a transcriptional program essential for pyruvate dehydrogenase activity. Proc. Natl. Acad. Sci. U.S.A.. 2016;113(39):10998-11003. doi:10.1073/pnas.1602754113


team

Team Leader :

Claude Sardet
 

Institut de Recherche en
Cancérologie de Montpellier
Campus Val d’Aurelle
34298 Montpellier cedex 5

 

 

 


 

Tél. : 33 (0)4 67 61 37 66
Fax : 33 (0)4 67 61 30 41

claude.sardet@inserm.fr

  

partners / funding

              


© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés